Cardiology

There are many medications with PGx implications and gene-drug interactions within the field of cardiology. 

Janet’s Story

Janet is a 71 year old African-American female with a history of cardiac arrest secondary to ventricular fibrillation. After resuscitation, Janet was not a candidate for an implanter cardioverter defibrillator (ICD).

“I was concerned that my medications would always be changing and putting me at greater risk.”

Cardiology Patient

Janet’s Story

Janet presented with an irregular heart rate while experiencing the sensation of it skipping a beat and chest discomfort. She was not experiencing dizziness nor fainting – but did have a singificant medical history including asthma, type 2 diabetes, and a previous myocardial infarction (MI).

Janet’s physician offered her a RightMed® test from OneOme. After taking the test, two current medications were identified as having major or moderate gene-drug interactions. Guidelines from the FDA were considered, and Janet’s doctor met with her to discuss the results.

Janet’s doctor was able to adjust her medications so she could get on with her busy and fulfilling life.